Panacea Biotec To Partner With US-Based Refana Inc For COVID-19 Vaccine
Panacea Biotec stated it is going to collaborate with Refana Inc for COVID vaccine (Representational)
Bengaluru:
Biotech company Panacea Biotec Ltd stated on Wednesday it will spouse with US-based Refana Inc to make a possible vaccine for COVID-19.
The collaboration objectives to make greater than 500 million doses of the vaccine candidate, with over 40 million doses anticipated to be to be had early subsequent 12 months, Panacea stated in a commentary to inventory exchanges.
Panacea’s stocks jumped 20% in morning buying and selling at the Nationwide Inventory Trade after the inside track.
